Immix Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMMX and other ETFs, options, and stocks.

About IMMX

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

CEO

Ilya Rachman

CEOIlya Rachman

Employees

Employees17

Headquarters

Los Angeles, California

HeadquartersLos Angeles, California

Founded

2012

Founded2012

Employees

Employees17

IMMX Key Statistics

Market cap

56.22M

Market cap56.22M

Price-Earnings ratio

-2.33

Price-Earnings ratio-2.33

Dividend yield

—

Dividend yield—

Average volume

165.30K

Average volume165.30K

High today

$2.29

High today$2.29

Low today

$2.02

Low today$2.02

Open price

$2.15

Open price$2.15

Volume

83.17K

Volume83.17K

52 Week high

$7.75

52 Week high$7.75

52 Week low

$1.40

52 Week low$1.40

Immix Biopharma

Why Robinhood?

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA. Show more

IMMX Key Statistics

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.